#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    NTRK gene fusion overexpression Ewing's sarcoma Hepatic angiosarcoma Ichthyosis Myasthenia gravis Loeys-Dietz syndrome Prophylaxis against transplant rejection Cortical dysplasia Acute on chronic liver failure Cardiac amyloidosis Hodgkin's disease recurrent Cerebral arteriovenous malformation haemorrhagic Chronic kidney disease B-cell type acute leukaemia Autologous haematopoietic stem cell transplant More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Basic Information Waldenstrom’s macroglobulinaemia recurrent Langerhans cell sarcoma – Basic Information Mantle cell lymphoma – Life with Disease Marfan’s syndrome Optic glioma – Treatment Nephrotic syndrome – Diagnostics Rhabdoid tumour – Trials in Disease Cystic fibrosis lung Sjogren’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oxybuprocaine GT-002 Fludeoxyglucose (18F) Sertindole Ixekizumab Envudeucitinib Erenumab Valproic Acid Selpercatinib Piritramide Elraglusib Iloprost Trometamol Cat Epithelia 2,4 DICHLOROBENZYL ALCOHOL Calcium Oxybate ANHYDROUS CALCIUM FOLINATE Warfarin Sodium Linerixibat Levetiracetam Sonidegib More therapies…

    Learn about Your Condition

    Bacterial infection Aplasia pure red cell Pneumothorax Lichenoid keratosis Adrenal insufficiency Abortion threatened Lung neoplasm malignant Infertility Ewing's sarcoma metastatic Diabetic retinal oedema Cervix carcinoma stage I Post procedural oedema Nervous system disorder Open angle glaucoma Gastrointestinal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Autoimmune disorder

  • Study Using PET Imaging to See How [89Zr]Zr-DFO-CIT-013 Spreads in Patients with Inflammatory Mediated Immune Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Autoimmune disorder
    Investigated Drugs:
    • [89ZR]ZR-DFO-CIT-013
    The Netherlands
  • Study on Anti-CD19 CAR T-Cell Therapy for Patients with Refractory Systemic Autoimmune Diseases Using Levetiracetam, Fludarabine, and a Drug Combination

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Autoimmune disorder
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Levetiracetam
    • Cyclophosphamide
    Italy
  • Study on Stopping Prednisone for Patients with Inflammatory or Autoimmune Disorders

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autoimmune disorder
    • Inflammation
    Investigated Drugs:
    • Prednisone
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!